Evolution of protease inhibitor resistance in HIV-1-infected patients failing protease inhibitor monotherapy as second-line therapy in low-income countries: an observational analysis within the EARNEST randomised trial

MLA

Thompson, J., et al. Evolution of Protease Inhibitor Resistance in HIV-1-Infected Patients Failing Protease Inhibitor Monotherapy as Second-Line Therapy in Low-Income Countries: An Observational Analysis within the EARNEST Randomised Trial. July 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..fb878f0e26c0514f0f2cfda330bb7d50&authtype=sso&custid=ns315887.

APA

Thompson, J., Kityo, C., Dunn, D., Hoppe, A., Ndashimye, E., Hakim, J., Kambugu, A., van Oosterhout, J., Arribas, J., Mugyenyi, P., Walker, A., & Paton, N. (2018). Evolution of protease inhibitor resistance in HIV-1-infected patients failing protease inhibitor monotherapy as second-line therapy in low-income countries: an observational analysis within the EARNEST randomised trial.

Chicago

Thompson, J, C Kityo, D Dunn, A Hoppe, E Ndashimye, J Hakim, A Kambugu, et al. 2018. “Evolution of Protease Inhibitor Resistance in HIV-1-Infected Patients Failing Protease Inhibitor Monotherapy as Second-Line Therapy in Low-Income Countries: An Observational Analysis within the EARNEST Randomised Trial,” July. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..fb878f0e26c0514f0f2cfda330bb7d50&authtype=sso&custid=ns315887.